Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.84
Delayed Data
As of Oct 20
 -0.26 / -0.63%
Today’s Change
37.20
Today|||52-Week Range
44.54
+6.05%
Year-to-Date
Glaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again?
Oct 20 / Zacks.com - Paid Partner Content
T Rowe Price Equity Income Fund Buys DowDuPont Inc, American International Group Inc,...
Oct 16 / GuruFocus News - Paid Partner Content
Novartis Reports Positive Results on Thrombocytopenia Drug
Oct 19 / Zacks.com - Paid Partner Content
Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada
Oct 16 / Zacks.com - Paid Partner Content
What to Expect from Big Pharmas After J&J's Solid Q3 Results?
Oct 18 / Zacks.com - Paid Partner Content
5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings
Oct 13 / Zacks.com - Paid Partner Content
T Rowe Price Equity Income Fund Adds 12 New Positions in 3rd Quarter
Oct 17 / GuruFocus News - Paid Partner Content
Pfizer Considering Sale/Spin-Off of Consumer Healthcare Unit
Oct 11 / Zacks.com - Paid Partner Content
FDA Grants Priority Review for Exelixis' RCC Drug Cabomteyx
Oct 17 / Zacks.com - Paid Partner Content